Tag Archives: physicians

A Global Consensus: Oncologists Spooked By Health Reforms

In a recent survey by Ipsos Healthcare, oncologists from the US, China, Brazil, and the EU Big 5, expressed strong dissatisfaction with the direction and pace of local healthcare initiatives. Conducted in February of this year, the survey indicates that a substantial portion of its 257 respondents—an average of 40% across these markets – are [...]
Posted in Global, Market Access, Regulatory, pricing | Also tagged , , , | Leave a comment

Physicians in ACOs Dare Pharma to Step up Its Game

Pharma, according to physicians currently embedded within Accountable Care Organizations (ACOs), is not living up to its potential. A survey conducted by Oliver Wyman has most of its 200 respondents saying the industry could play a more active role with value-based healthcare providers in helping to deliver better care at a lower cost, but it [...]
Posted in Strategy, healthcare | Also tagged , , , | Leave a comment

Mapping Opportunities with the Non-Physician Prescriber

They write 92% of their prescriptions without consulting a physician and are often the first provider a patient sees, and yet nurse practitioners, physician’s assistants and other non-physician prescribers (NPPs) are still somehow overlooked by pharma as an opportunity to drive sales. A GSW Worldwide report titled The non-physician prescriber will see you now points [...]
Posted in Advertising, Marketing, Patient Communication, Sales, Strategy, compliance, healthcare, patient compliance, patient education | Also tagged , , , , , , , , , , , | Leave a comment

Oncologists, in Detail

On average, cancer docs in the US would much rather deal with pharma sales reps in person as opposed to online, and drug companies are hiring more reps to support a slew of newly approved oncologic drugs, even as reps in other therapeutic areas get pink slips. But external pressures are likely to further limit [...]
Posted in Advertising, Sales, healthcare, social media | Also tagged , , | Leave a comment

What Key Opinion Leaders Really Want from Pharma

Increased scrutiny and new regulation have seen pharma’s relationship with key opinion leaders (KOLs) undergo a paradigm shift in recent years. Sales and marketing teams are no longer the preferred point of contact, explains Dr Samuel Dyer of the Medical Science Liaison Society. Historically, pharma companies have believed that their sales and marketing teams are of [...]
Posted in Guest Blog, Op-Ed | Also tagged , , | 2 Comments